Metacrine Ownership 2024 | Who Owns Metacrine Now?
Institutional Ownership
21.82%
Insider Ownership
14.78%
Retail Ownership
63.40%
Institutional Holders
5.00
Metacrine Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 14.49% | 3.04% | 6,167,458 | - | - | 3,519,152,000 | Mar 31, 2023 |
| JBF CAPITAL, INC. | 4.57% | 0.25% | 1,945,270 | 1,945,270 | 100.00% | 1,109,971,000 | Mar 31, 2023 |
| ARTAL GROUP S.A. | 2.17% | 0.03% | 924,898 | - | - | 528,000 | Mar 31, 2023 |
| TUDOR INVESTMENT CORP ET AL | 0.56% | 0.00% | 239,100 | -70,927 | -22.88% | 136,000 | Mar 31, 2023 |
| WEDBUSH SECURITIES INC | 0.03% | 0.00% | 12,700 | - | - | 7,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -40 | -100.00% | - | Mar 31, 2023 |
| NEWSQUARE CAPITAL LLC | - | - | - | -600 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -69,435 | -100.00% | - | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -241 | -100.00% | - | Mar 31, 2023 |
| ALLWORTH FINANCIAL LP | - | - | - | -500 | -100.00% | - | Mar 31, 2023 |
| EDGE WEALTH MANAGEMENT LLC | - | - | - | -11,000 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -44,200 | -100.00% | - | Mar 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -26,163 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -72,186 | -100.00% | - | Mar 31, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -204,023 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -574,636 | -100.00% | - | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -18,413 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -76,235 | -100.00% | - | Mar 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -254,492 | -100.00% | - | Mar 31, 2023 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -4,250,000 | -100.00% | - | Mar 31, 2023 |
Metacrine's largest institutional shareholder is BML CAPITAL MANAGEMENT, LLC, holding 14.49% of the company's total share outstanding, currently valued at $3.52B. The top 10 institutional shareholders own together 21.82% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 14.49% | 3.04% | 6,167,458 | - | - | 3,519,152,000 | Mar 31, 2023 |
| JBF CAPITAL, INC. | 4.57% | 0.25% | 1,945,270 | 1,945,270 | 100.00% | 1,109,971,000 | Mar 31, 2023 |
| ARTAL GROUP S.A. | 2.17% | 0.03% | 924,898 | - | - | 528,000 | Mar 31, 2023 |
| TUDOR INVESTMENT CORP ET AL | 0.56% | 0.00% | 239,100 | -70,927 | -22.88% | 136,000 | Mar 31, 2023 |
| WEDBUSH SECURITIES INC | 0.03% | 0.00% | 12,700 | - | - | 7,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -40 | -100.00% | - | Mar 31, 2023 |
| NEWSQUARE CAPITAL LLC | - | - | - | -600 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -69,435 | -100.00% | - | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -241 | -100.00% | - | Mar 31, 2023 |
| ALLWORTH FINANCIAL LP | - | - | - | -500 | -100.00% | - | Mar 31, 2023 |
| EDGE WEALTH MANAGEMENT LLC | - | - | - | -11,000 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -44,200 | -100.00% | - | Mar 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -26,163 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -72,186 | -100.00% | - | Mar 31, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -204,023 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -574,636 | -100.00% | - | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -18,413 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -76,235 | -100.00% | - | Mar 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -254,492 | -100.00% | - | Mar 31, 2023 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -4,250,000 | -100.00% | - | Mar 31, 2023 |
The largest Metacrine shareholder by % of total assets is BML CAPITAL MANAGEMENT, LLC. The company owns 6.17M shares of Metacrine (MTCR), representing 3.04% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JBF CAPITAL, INC. | 4.57% | 0.25% | 1,945,270 | 1,945,270 | 100.00% | 1,109,971,000 | Mar 31, 2023 |
| WEDBUSH SECURITIES INC | 0.03% | 0.00% | 12,700 | - | - | 7,000 | Mar 31, 2023 |
| ARTAL GROUP S.A. | 2.17% | 0.03% | 924,898 | - | - | 528,000 | Mar 31, 2023 |
| BML CAPITAL MANAGEMENT, LLC | 14.49% | 3.04% | 6,167,458 | - | - | 3,519,152,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -40 | -100.00% | - | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -241 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -500 | -100.00% | - | Mar 31, 2023 |
| ALLWORTH FINANCIAL LP | - | - | - | -500 | -100.00% | - | Mar 31, 2023 |
| NEWSQUARE CAPITAL LLC | - | - | - | -600 | -100.00% | - | Mar 31, 2023 |
| TRIFECTA CAPITAL ADVISORS, LLC | - | - | - | -4,000 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -4,781 | -100.00% | - | Mar 31, 2023 |
| EDGE WEALTH MANAGEMENT LLC | - | - | - | -11,000 | -100.00% | - | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -18,413 | -100.00% | - | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | - | - | - | -24,060 | -100.00% | - | Mar 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -26,163 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -44,200 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -69,435 | -100.00% | - | Mar 31, 2023 |
| TUDOR INVESTMENT CORP ET AL | 0.56% | 0.00% | 239,100 | -70,927 | -22.88% | 136,000 | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -72,186 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -76,235 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Metacrine's largest institutional buyer is JBF CAPITAL, INC.. The company purchased 1.95M stocks of MTCR, valued at $1.11B.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -4,250,000 | -100.00% | - | Mar 31, 2023 |
| ARCH VENTURE MANAGEMENT, LLC | - | - | - | -2,940,503 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -574,636 | -100.00% | - | Mar 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -254,492 | -100.00% | - | Mar 31, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -204,023 | -100.00% | - | Mar 31, 2023 |
| BLACKROCK INC. | - | - | - | -100,444 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -97,033 | -100.00% | - | Mar 31, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -88,364 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -76,235 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -72,186 | -100.00% | - | Mar 31, 2023 |
| TUDOR INVESTMENT CORP ET AL | 0.56% | 0.00% | 239,100 | -70,927 | -22.88% | 136,000 | Mar 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -69,435 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -44,200 | -100.00% | - | Mar 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -26,163 | -100.00% | - | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | - | - | - | -24,060 | -100.00% | - | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -18,413 | -100.00% | - | Mar 31, 2023 |
| EDGE WEALTH MANAGEMENT LLC | - | - | - | -11,000 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -4,781 | -100.00% | - | Mar 31, 2023 |
| TRIFECTA CAPITAL ADVISORS, LLC | - | - | - | -4,000 | -100.00% | - | Mar 31, 2023 |
| NEWSQUARE CAPITAL LLC | - | - | - | -600 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Metacrine's biggest institutional seller is TANG CAPITAL MANAGEMENT LLC. The company sold -4.25M shares of MTCR, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JBF CAPITAL, INC. | 4.57% | 0.25% | 1,945,270 | 1,945,270 | 100.00% | 1,109,971,000 | Mar 31, 2023 |
Metacrine's largest new institutional shareholder by number of shares is JBF CAPITAL, INC., purchased 1.95M shares, valued at $1.11B, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -4,250,000 | -100.00% | - | Mar 31, 2023 |
| ARCH VENTURE MANAGEMENT, LLC | - | - | - | -2,940,503 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -574,636 | -100.00% | - | Mar 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -254,492 | -100.00% | - | Mar 31, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -204,023 | -100.00% | - | Mar 31, 2023 |
| BLACKROCK INC. | - | - | - | -100,444 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -97,033 | -100.00% | - | Mar 31, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -88,364 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -76,235 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -72,186 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -69,435 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -44,200 | -100.00% | - | Mar 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -26,163 | -100.00% | - | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | - | - | - | -24,060 | -100.00% | - | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -18,413 | -100.00% | - | Mar 31, 2023 |
| EDGE WEALTH MANAGEMENT LLC | - | - | - | -11,000 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -4,781 | -100.00% | - | Mar 31, 2023 |
| TRIFECTA CAPITAL ADVISORS, LLC | - | - | - | -4,000 | -100.00% | - | Mar 31, 2023 |
| NEWSQUARE CAPITAL LLC | - | - | - | -600 | -100.00% | - | Mar 31, 2023 |
| ALLWORTH FINANCIAL LP | - | - | - | -500 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -500 | -100.00% | - | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -241 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -40 | -100.00% | - | Mar 31, 2023 |
Metacrine's largest sold out institutional shareholder by shares sold is TANG CAPITAL MANAGEMENT LLC, sold -4.25M shares, valued at -, as of undefined.
Metacrine Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| MERIDIAN FUND INC | 0.12% | 432,584 | - | - | Dec 29, 2023 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.06% | 10,531 | - | - | Dec 29, 2023 |
| BRIDGEWAY FUNDS INC | 0.04% | 90,000 | - | - | Dec 29, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 312,500 | - | - | Feb 29, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,018 | - | - | Dec 31, 2023 |
| SEASONS SERIES TRUST | 0.00% | 26,725 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.00% | 254,492 | - | - | Dec 31, 2023 |
| SCHWAB CAPITAL TRUST | 0.00% | 13,800 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 66,850 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 555 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 2,323 | - | - | Dec 31, 2023 |
| FIDELITY SALEM STREET TRUST | 0.00% | 48,410 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 52,751 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 143 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 1,200 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 3,138 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 20,412 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 1,193 | - | - | Dec 31, 2023 |
| Dimensional ETF Trust | 0.00% | 3,360 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 4,210 | - | - | Dec 29, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 545 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 59 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 3,798 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 3,071 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 36,356 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 715 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 4,716 | - | - | Dec 31, 2023 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 4,751 | - | - | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 819 | - | - | Dec 31, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,025 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 2,178 | - | - | Dec 31, 2023 |
| BLACKROCK FUNDS | 0.00% | 1,284 | - | - | Feb 29, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,123 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 2,793 | - | - | Feb 29, 2024 |
Metacrine's largest mutual fund holder by % of total assets is "MERIDIAN FUND INC", owning 432.58K shares, compromising 0.12% of its total assets.
Metacrine Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 23 | 5 | -80.77% |
| 31 Dec, 22 | 26 | 23.81% |
| 30 Sep, 22 | 21 | 5.00% |
| 30 Jun, 22 | 20 | -31.03% |
| 31 Mar, 22 | 29 | -3.33% |
| 31 Dec, 21 | 30 | -6.25% |
| 30 Sep, 21 | 32 | -17.95% |
| 30 Jun, 21 | 39 | -15.22% |
| 31 Mar, 21 | 46 | 12.20% |
| 31 Dec, 20 | 41 | 57.69% |
| 30 Sep, 20 | 26 | - |
As of 31 Mar 23, 5 institutions are holding Metacrine's shares, representing a decrease of -80.77% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 23 | 9,289,426 | -42.84% |
| 31 Dec, 22 | 16,252,872 | 101.77% |
| 30 Sep, 22 | 8,055,007 | 32.59% |
| 30 Jun, 22 | 6,074,908 | -2.89% |
| 31 Mar, 22 | 6,255,731 | 90.66% |
| 31 Dec, 21 | 3,281,110 | -70.19% |
| 30 Sep, 21 | 11,007,432 | -11.73% |
| 30 Jun, 21 | 12,470,294 | -5.81% |
| 31 Mar, 21 | 13,238,958 | -0.29% |
| 31 Dec, 20 | 13,276,809 | -2.19% |
| 30 Sep, 20 | 13,573,652 | - |
Metacrine (MTCR) has 9.29M shares outstanding as of 31 Mar 23, down -42.84% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 23 | 21.82% | 1.50% |
| 31 Dec, 22 | 38.18% | 10.66% |
| 30 Sep, 22 | 18.92% | 9.23% |
| 30 Jun, 22 | 14.32% | 6.49% |
| 31 Mar, 22 | 14.85% | 24.46% |
| 31 Dec, 21 | 7.79% | 0.45% |
| 30 Sep, 21 | 41.50% | 1.86% |
| 30 Jun, 21 | 47.29% | 1.85% |
| 31 Mar, 21 | 50.51% | 1.93% |
| 31 Dec, 20 | 51.12% | 1.87% |
| 30 Sep, 20 | 52.27% | - |
As of 31 Mar 23, Metacrine is held by 21.82% institutional shareholders, representing a 1.50% growth compared to 31 Dec 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 1 | -90.91% |
| 31 Dec, 22 | 11 | 37.50% |
| 30 Sep, 22 | 8 | 60.00% |
| 30 Jun, 22 | 5 | -73.68% |
| 31 Mar, 22 | 19 | 11.76% |
| 31 Dec, 21 | 17 | 13.33% |
| 30 Sep, 21 | 15 | -11.76% |
| 30 Jun, 21 | 17 | - |
| 31 Mar, 21 | 17 | -41.38% |
| 31 Dec, 20 | 29 | 11.54% |
| 30 Sep, 20 | 26 | - |
1 institutional shareholders have increased their position in MTCR stock as of 31 Mar 23 compared to 11 in the previous quarter (a -90.91% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 23 | 1 | -83.33% |
| 31 Dec, 22 | 6 | 50.00% |
| 30 Sep, 22 | 4 | -50.00% |
| 30 Jun, 22 | 8 | 100.00% |
| 31 Mar, 22 | 4 | -20.00% |
| 31 Dec, 21 | 5 | -37.50% |
| 30 Sep, 21 | 8 | -38.46% |
| 30 Jun, 21 | 13 | -13.33% |
| 31 Mar, 21 | 15 | 150.00% |
| 31 Dec, 20 | 6 | - |
| 30 Sep, 20 | - | - |
1 institutional shareholders have reduced their position in MTCR stock as of 31 Mar 23 compared to 6 in the previous quarter (a -83.33% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 23 | 5 | -80.77% | 9,289,426 | -42.84% | 21.82% | 1.50% | 1 | -90.91% | 1 | -83.33% |
| 31 Dec, 22 | 26 | 23.81% | 16,252,872 | 101.77% | 38.18% | 10.66% | 11 | 37.50% | 6 | 50.00% |
| 30 Sep, 22 | 21 | 5.00% | 8,055,007 | 32.59% | 18.92% | 9.23% | 8 | 60.00% | 4 | -50.00% |
| 30 Jun, 22 | 20 | -31.03% | 6,074,908 | -2.89% | 14.32% | 6.49% | 5 | -73.68% | 8 | 100.00% |
| 31 Mar, 22 | 29 | -3.33% | 6,255,731 | 90.66% | 14.85% | 24.46% | 19 | 11.76% | 4 | -20.00% |
| 31 Dec, 21 | 30 | -6.25% | 3,281,110 | -70.19% | 7.79% | 0.45% | 17 | 13.33% | 5 | -37.50% |
| 30 Sep, 21 | 32 | -17.95% | 11,007,432 | -11.73% | 41.50% | 1.86% | 15 | -11.76% | 8 | -38.46% |
| 30 Jun, 21 | 39 | -15.22% | 12,470,294 | -5.81% | 47.29% | 1.85% | 17 | - | 13 | -13.33% |
| 31 Mar, 21 | 46 | 12.20% | 13,238,958 | -0.29% | 50.51% | 1.93% | 17 | -41.38% | 15 | 150.00% |
| 31 Dec, 20 | 41 | 57.69% | 13,276,809 | -2.19% | 51.12% | 1.87% | 29 | 11.54% | 6 | - |
| 30 Sep, 20 | 26 | - | 13,573,652 | - | 52.27% | - | 26 | - | - | - |
Metacrine Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Metacrine's stock was made by Klassen Preston on Mar 24 2023, selling 842,211 shares at $0.47 per share (valued at $395.84K). The last insider buy of MTCR was made by Leonard Braden Michael on Dec 21 2022, buying 120,099 shares at $0.40 per share (worth $48.04K).
Metacrine Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2023 | - | 4 | - |
| Q4 2022 | 11 | 1 | 1100.00% |
| Q2 2022 | 8 | 1 | 800.00% |
| Q1 2022 | 4 | 1 | 400.00% |
| Q4 2021 | - | 29 | - |
| Q2 2021 | 13 | - | - |
| Q1 2021 | 5 | - | - |
| Q4 2020 | - | 1 | - |
| Q3 2020 | 66 | 66 | 100.00% |
0 total buy trades, and 4 total sell trades (buy/sell ratio of 0.00%) were made by Metacrine's insiders, as of Q1 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2023 | - | 2 | - |
| Q4 2022 | 11 | - | - |
| Q2 2022 | - | 1 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 29 | - |
| Q2 2021 | 2 | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 21 | - | - |
As of Q1 2023, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Metacrine's stocks.
Metacrine Peer Ownership
| Ticker | Company |
|---|---|
| ANEB | Anebulo Pharmaceuticals, Inc. |
| SRZN | Surrozen, Inc. |
| TIL | Instil Bio, Inc. |
| NUVB | Nuvation Bio Inc. |
| MGTA | Dianthus Therapeutics, Inc. |
| INDP | Indaptus Therapeutics, Inc. |
| TCON | TRACON Pharmaceuticals, Inc. |
| CTMX | CytomX Therapeutics, Inc. |
| MNPR | Monopar Therapeutics Inc. |
| TARA | Protara Therapeutics, Inc. |
| NLTX | Neurogene Inc. |
| ASMB | Assembly Biosciences, Inc. |
| VCNX | Vaccinex, Inc. |
MTCR Ownership FAQ
Who Owns Metacrine?
Metacrine is owned by institutional shareholders (21.82%), insiders (14.78%), and public (63.40%). The largest institutional shareholder of Metacrine is BML CAPITAL MANAGEMENT, LLC (14.49% of total shares) and the top mutual fund owner is MERIDIAN FUND INC (0.12% of total shares).
Who are the major institutional shareholders of Metacrine?
Metacrine's major institutional shareholders are BML CAPITAL MANAGEMENT, LLC, JBF CAPITAL, INC., ARTAL GROUP S.A., TUDOR INVESTMENT CORP ET AL, and WEDBUSH SECURITIES INC. The top five shareholders own together 21.82% of the company's share outstanding.
How many Metacrine shareholders are there?
As of Mar 2023, there are 5 institutional shareholders of Metacrine.
What percentage of Metacrine is owned by BML CAPITAL MANAGEMENT, LLC?
BML CAPITAL MANAGEMENT, LLC owns 6.17M shares of Metacrine, representing 14.49% of the company's total shares outstanding, valued at $3.52B (as of Mar 2023).
What percentage of Metacrine is owned by JBF CAPITAL, INC?
As of Mar 2023, JBF CAPITAL, INC holds 1.95M shares of Metacrine (MTCR), compromising 4.57% of the company, valued at $1.11B.
What percentage of Metacrine is owned by ARTAL GROUP S.A?
ARTAL GROUP S.A is the third largest holder of Metacrine. The company owns 924.9K of the company's shares outstanding (worth $528K).